---
figid: PMC3907121__nihms546616f1
figlink: /pmc/articles/PMC3907121/figure/F1/
number: Figure 1
caption: Binding of EPO to either the homodimeric EPO-receptor (EPOR) complex or the
  heterotrimeric EPOR-βCR complex first activates Janus tyrosine kinase 2 (Jak2).
  Phosphorylation and activation of Jak2 recruits secondary messengers and activates
  secondary signaling pathways including phosphatidylinositol 3-kinase (PI3K), mitogen-activated
  protein kinase (MAPK), and nuclear factor-κB. Some of the pathways mediating EPO-mediated
  protection are similar to those mediating erythropoiesis or neuroprotection. In
  particular, EPO-mediated inhibition of apoptosis involves activation of protein
  kinase B/Akt to inhibit caspase-9 or activate nuclear factor kappa B (NFκB) or inhibit
  Bad, or stimulate signal transducer and activator of transcription (STAT), or MAPK
  pathway to increase anti-apoptotic messengers in the mitochondria including Bcl-2
  and Bcl-xL. The most common pathway for EPO-mediated cardioprotection as well as
  vascular protection is EPO-induced augmentation of nitric oxide (NO) production
  by PI3K/Akt phosphorylation and activation of endothelial nitric oxide synthase
  (eNOS). EPO is also shown to regulate intracellular Ca2+ by activating phospholipase
  C (PLC).
pmcid: PMC3907121
papertitle: 'Cardiovascular Effects of Erythropoietin: An Update.'
reftext: Anantha Vijay R. Santhanam, et al. Adv Pharmacol. ;60:257-285.
pmc_ranked_result_index: '116290'
pathway_score: 0.9639599
filename: nihms546616f1.jpg
figtitle: 'Cardiovascular Effects of Erythropoietin: An Update'
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3907121__nihms546616f1.html
  '@type': Dataset
  description: Binding of EPO to either the homodimeric EPO-receptor (EPOR) complex
    or the heterotrimeric EPOR-βCR complex first activates Janus tyrosine kinase 2
    (Jak2). Phosphorylation and activation of Jak2 recruits secondary messengers and
    activates secondary signaling pathways including phosphatidylinositol 3-kinase
    (PI3K), mitogen-activated protein kinase (MAPK), and nuclear factor-κB. Some of
    the pathways mediating EPO-mediated protection are similar to those mediating
    erythropoiesis or neuroprotection. In particular, EPO-mediated inhibition of apoptosis
    involves activation of protein kinase B/Akt to inhibit caspase-9 or activate nuclear
    factor kappa B (NFκB) or inhibit Bad, or stimulate signal transducer and activator
    of transcription (STAT), or MAPK pathway to increase anti-apoptotic messengers
    in the mitochondria including Bcl-2 and Bcl-xL. The most common pathway for EPO-mediated
    cardioprotection as well as vascular protection is EPO-induced augmentation of
    nitric oxide (NO) production by PI3K/Akt phosphorylation and activation of endothelial
    nitric oxide synthase (eNOS). EPO is also shown to regulate intracellular Ca2+
    by activating phospholipase C (PLC).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK2
  - MAPK1
  - IKBKB
  - CHUK
  - HRAS
  - KRAS
  - AKT3
  - IKBKG
  - AKT1
  - BAD
  - MAPK13
  - AKT2
  - STAT3
  - NOS3
  - GSK3B
  - BCR
  - GRB2
  - BRAF
  - MAPK3
  - BCL2
  - NRAS
  - SHC2
  - MAPK10
  - EPO
  - BCL2L1
  - MAPK9
  - SHC3
  - SHC4
  - GSK3A
  - RAF1
  - STAT5A
  - RELB
  - SHC1
  - MAP2K2
  - ARAF
  - MAPK12
  - SART3
  - STAT5B
  - MAPK8
  - MAPK11
  - NFKB1
  - EPOR
  - MAPK14
  - REL
  - RELA
  - NFKB2
  - MAP2K1
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Bad
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: STAT3/5P
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: ENOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: BCR
  symbol: BCR
  source: hgnc_symbol
  hgnc_symbol: BCR
  entrez: '613'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: EPO
  symbol: EPO
  source: hgnc_symbol
  hgnc_symbol: EPO
  entrez: '2056'
- word: Bcl-xL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: STAT3/5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: p110)
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: STAT3/5
  symbol: STAT5
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: EPOR
  symbol: EPOR
  source: hgnc_symbol
  hgnc_symbol: EPOR
  entrez: '2057'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
